Follow the 프레스티지바이오파마 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 프레스티지바이오파마 has recorded 52 reports. The latest transaction was reported on 9 July 2026 (Purchase). Among the most active insiders: 옥타바펀드리미티드. Every trade is free.
43
Insider Decl.
n/a
Thresholds
n/a
19 ops.
Buy Volume
n/a
n/a
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Prestige Biopharma is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development of innovative biologic drugs.